Publication Date
| In 2025 | 0 |
| Since 2024 | 1 |
| Since 2021 (last 5 years) | 1 |
| Since 2016 (last 10 years) | 1 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Attention Deficit… | 1 |
| Drug Therapy | 1 |
| Foreign Countries | 1 |
| Medicine | 1 |
| Merchandise Information | 1 |
| Patients | 1 |
| Pediatrics | 1 |
Publication Type
| Information Analyses | 1 |
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
| Australia | 1 |
| Canada | 1 |
| New Zealand | 1 |
| United Kingdom | 1 |
| United States | 1 |
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkLaila Tanana; Asam Latif; Prasad S. Nishtala; Timothy F. Chen – Journal of Attention Disorders, 2024
Objective: This study aimed to compare the approval of medicines for attention deficit/hyperactivity disorder (ADHD) for pediatric patients across five countries. Method: A document analysis was completed, using the drug labeling for ADHD medicines from five countries; United Kingdom, Australia, New Zealand, Canada and United States (US).…
Descriptors: Medicine, Drug Therapy, Attention Deficit Hyperactivity Disorder, Merchandise Information
